Background: The aim of this paper is to investigated the contribution of adipose tissue thought the adipokines and kidney failure (KF)
Methods: In male rats were fed with a standard lab diet (C) or a hypercaloric diet including 30% sucrose; obese group (Ob) and obese with kidney failure group (Ob/KF). We evaluated the changes of adipokines under conditions of obesity and KF, using 5/6 surgery to induce vascular injury. The anterior and media branches of the left kidney artery were tied together, leaving the posterior branch viable to enable the kidney to function. The right kidney was removed.
Results: A 90% survival rate of the animals was achieved due to special care taken. Kidney function progressively decreased after surgery. Compared with the control group, in the other two groups (Ob and Ob/KF) the level of leptin increased and that of adiponectin decreased (p < 0.01). Post-surgery increases were observed in blood pressure, lipids, creatinine and insulin (p < 0.01).
Conclusion: This model is proposed for the study pathophysiological mechanisms that lead to obesity and complications of kidney or cardiovascular function.
Selassie M, Sinha AC. The epidemiology and aetiology of obesity: A global challenge. Best Practice and Research Clinical Anaesthesiology. 2011;25:1-9.
Yu M, Lyles C, Bent-Shaw L, Young B. Risk factor, age and sex differences in chronic kidney disease prevalence in a diabetic cohort: The pathways study. American Journal of Nephrology. 2012;36:245-251.
Alkhunazi AM, Schrier RW. Management of acute renal failure: New perspective. American Journal of Kidney Diseases. 1996;28(3):315-328.
Fuster V. Cardiovascular disease and the UN Millennium Development Goals: A serious concern. Nature Clinical Practice Cardiovascular Medicine. 2006;3:401.
Amsalem Y, Garty M, Schwartz R, Sandach A, Behar S, Caspi A, et al. Prevalence and significance of unrecognized renal insufficiency in patients with heart failure. European Heart Journal. 2008;29:1029-1036.
Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprise: Part I: aging arteries: a ‘set up’ for vascular disease. Circulation. 2003;107:139-46.
Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE. Oxford Vascular Study. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet. 2005;366:1773-1778.
Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology. 2006;6:772-783.
Alzamendi A, Giovambattista A, Raschia A, Madrid V, Gaillard RC, Rebolledo O, Gagliardino JJ, Spinedi E. Fructose-rich diet-induced abdominal adipose tissue endocrine dysfunction in normal male rats. Endocrine. 2009;35:227-232.
Meijer RI, Serne EH, Smulders YM, van Hinsbergh VW, Yudkin JS, Eringa EC. Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease. Current Diabetes Reports. 2011;11:211-217.
Manuel-Apolinar L, Zárate A, Rocha L, Hernández-Valencia, M. Fetal malnutrition affects hypothalamic leptin receptor expression after birth in mice. Archives of Medical Research. 2010;41:240-245.
Barker DJ, Hales CN, Fall CH. Type 2 (non-insulindependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): Relation to reduced fetal growth. Diabetologia. 1993;36:62-67.
Harder T, Rodekamp E, Schellong K, Dudenhausen JW. Birth Weight and Subsequent Risk of Type 2 Diabetes: A Meta-Analysis. American Journal of Epidemiology. 2007;165:849-857.
Johnson RJ, Segal MS, Sautin Y. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. The American Journal of Clinical Nutrition. 2007;86:899-906.
Shapiro A, Mu W, Roncal C, Cheng KY, Johnson RJ, Scarpace PJ. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2008;295:R1370-R1375.
Weening JJ, Beukers JJ, Grond J, Elema JD. Genetic factors in focal segmental glomerulosclerosis. Kidney International. 1986;29:789-798.
Flores O, Arévalo M, Gallego B, Hidalgo F, Vidal S, López-Novoa JM. Beneficial effects of the long-term treatment with the combination of an ACE inhibitor and a calcium channel blocker on renal injury in rats with 5/6 nephrectomy. Experimental Nephrology. 1998;6:39-49.
Zhang R, Reisin E. Obesity-hypertension: the effects on cardiovascular and renal system. American Journal of Hypertension. 2000;13:1308-1314.
Gallardo JM, Prado-Uribe C, Amato D, Paniagua R. Inflammation and oxidative stress markers by pentoxifylline treatment in rats with chronic renal failure and high sodium intake. Archives of Medical Research. 2007;38:34-38.
Berkalp B, Cesur V, Corapcioglu D, Erol C, Baskal N. Obesity and left ventricular diastolic dysfunction. International Journal of Cardiology. 1995;52:23-26.
Fortuño A, Rodríguez A, Gómez-Ambrosi J, Frühbeck G, Díez J. Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. Journal of Physiology and Biochemistry. 2003;59:51-60.
Ouchi N, Ohishi M, Kihara S, Funahashi T. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 2003;42:231-234.
Higuchi Y, Otsu K, Nishida K, Hirotani S, Nakayama H, Yamaguchi O. Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF alpha-induced cardiomyocyte hypertrophy. Journal of Molecular and Cellular Cardiology. 2002;34:233-240.
LaGuire T, Kohlen C, Hawk S, Reaves S. The effects of aging on muscle loss and tissue-specific levels of NF-kB and SIRT6 protein in rats. Adv Aging Res. 2003;2:1-9.
Cruz-Laguna E, Gamez-Méndez AM, Vargas H, Ríos A, Méndez A, Escalante B. Renin-angiotensin system blockade: Effect on renal mRNA expression in 5/6 nephrectomized rats. Health. 2013;5:9-15.
Moringo R, Musri M, Vidal J. Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes. Obesity Surg. 2006;16:745-751.